Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study

OBJECTIVES: Refractory major depressive disorder (MDD) is a serious problem leading to a heavy economic burden. Antipsychotic augmentation treatment with aripiprazole and quetiapine is approved for MDD patients and can achieve a high remission rate. This study aimed to examine how psychiatrists in T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Yi-Chien, Chou, Yu-Ching, Chang, Hsin-An, Kao, Yu-Chen, Huang, San-Yuan, Tzeng, Nian-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315562/
https://www.ncbi.nlm.nih.gov/pubmed/25657586
http://dx.doi.org/10.2147/NDT.S75609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315562/
https://www.ncbi.nlm.nih.gov/pubmed/25657586
http://dx.doi.org/10.2147/NDT.S75609

Ejemplares similares